Robotic Endoscopy Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic, Therapeutic), By Applications (Laparoscopy, Bronchoscopy, Colonoscopy, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Robotic Endoscopy Devices Market Size

The global robotic endoscopy devices market size was valued at USD 2.29 billion in 2024 and is projected to grow from USD 2.49 billion in 2025 to reach USD 5.01 billion by 2033, exhibiting a CAGR of 9.1% during the forecast period (2025-2033).

Robotic endoscopy devices are cutting-edge medical instruments that integrate robotics with endoscopic techniques, enhancing precision, control, and visualization during minimally invasive surgeries. The market for these devices is expanding rapidly, driven by the increasing demand for minimally invasive procedures across multiple regions and continuous technological advancements in endoscopy.

Moreover, a notable rise in patent filings for robotic endoscopy devices in the Patent Cooperation Treaty (PCT) and the United States reflects ongoing innovation and investment in this field. As these devices gain wider acceptance, they are expected to transform surgical practices, reduce patient recovery times, and improve overall clinical outcomes.

The table represents the patent analysis of the global market

Source: World Intellectual Property Rights (WIPO) and Straits Analysis

The United States registered the maximum number of patents in 2023 and 2024. Followed by the United States PCT registered 7 patents, the European Patent Office registered 5 patents, China registered 2 patents, and the United Kingdom registered 1 patent for a robotic endoscopy device.

Robotic Endoscopy Devices Market Trends

Integration of artificial intelligence

The incorporation of artificial intelligence into these devices is revolutionizing surgical practices by enhancing image analysis and supporting real-time decision-making. AI-driven algorithms can analyze vast datasets, providing surgeons with critical insights throughout procedures, leading to more accurate and effective outcomes.

• For example, Medtronic plc has developed the GI Genius Intelligent Endoscopy Module, the first AI-powered polyp detection system on the market. This advanced module has demonstrated a 14.4% increase in adenoma detection rates (ADR), significantly improving early diagnosis and patient safety.

Innovative AI-enabled systems like these are enhancing patient safety and elevating standards in both diagnostics and surgical precision.

Robotic Endoscopy Devices Market Growth Factors

Rising incidences of chronic diseases

The growing prevalence of chronic diseases, including cancer and gastrointestinal disorders, is driving demand for advanced surgical diagnostic tools such as robotic endoscopic devices. These devices provide precision and minimally invasive options crucial for diagnosing and treating complex conditions, thus contributing to market growth.

• For example, a 2023 report by Lancet Publication estimated that over 332 million people are affected by digestive disorders in Europe alone, highlighting the significant need for advanced medical solutions.
• Additionally, the American Association for Cancer Research (AACR) reported that over 18 million people in the United States were living with cancer as of January 2022.

The rising incidence of chronic diseases worldwide is fueling the adoption of robotic endoscopy devices as healthcare providers seek more effective and less invasive diagnostic tools to enhance patient care.

Growing demand for minimally invasive surgeries

The increasing preference for minimally invasive surgeries is a significant growth driver for the global robotic endoscopy devices market. Patients and healthcare providers favor these procedures due to their benefits, including shorter recovery times, reduced pain, and minimal scarring. This shift is accelerating the adoption of robotic endoscopy devices, which enhance the precision and control required in minimally invasive techniques.

• For example, data from the National Center for Biotechnology Information (NCBI) reveals that out of 9.8 million major inpatient operating room procedures, approximately 11% were minimally invasive surgeries, reflecting the growing trend toward less invasive approaches.

The rising demand for minimally invasive options is propelling the need for advanced robotic-assisted endoscopy devices, as they allow for safer, more efficient surgical outcomes in line with patient and provider expectations.

Market Restraining Factors

High cost of robotic endoscopy devices

The substantial cost of robotic-assisted endoscopy devices is a primary factor limiting their adoption, particularly among smaller healthcare facilities and hospitals with limited budgets. Though highly effective, these advanced devices represent a significant financial investment, creating a barrier to widespread use and slowing market growth.

• For example, according to Medorah Meditek, the price for advanced endoscopy devices starts at around $3,600 and can increase significantly depending on the technology and features.

This high cost limits accessibility for many healthcare providers, thereby impacting the overall market growth as only larger or better-funded institutions are more likely to afford and implement these advanced surgical tools.

Market Opportunities

Miniaturization of robotic endoscopy device

The trend towards miniaturized and portable robotic endoscopy devices presents a promising opportunity for expanding their use across a broader range of surgical procedures. These compact devices offer greater flexibility and accessibility, making them ideal for minimally invasive surgeries in diverse medical settings.

• For example, KARL STORZ's EndoCAMeleon, a rigid endoscope with an adjustable lens angle, provides a customizable field of view from 0° to 120°, controlled by a wheel on the instrument handle. This feature enables surgeons to perform more precise procedures with enhanced visualization and control.

Advancements in device miniaturization and adaptability not only improve surgical precision but also make robotic endoscopy more accessible to a wider range of healthcare facilities. This opportunity enhances patient outcomes by expanding the use of robotic-assisted endoscopy in minimally invasive surgeries, addressing the growing demand for safer and more efficient treatment options.

Regional Insights

North America: Dominant region with 41.75% market share

North America remains the largest market for robotic endoscopy devices, supported by its advanced healthcare infrastructure, substantial R&D investments, and the presence of major medical device companies like Stryker Corporation, Johnson & Johnson, and Olympus Corporation. This concentration of industry leaders accelerates innovation and product development in the region.

Moreover, North America’s robust regulatory environment and the high adoption rate of cutting-edge healthcare technologies drive market expansion as hospitals and clinics increasingly integrate robotic endoscopy solutions to improve patient outcomes and surgical precision. Rising cases of chronic diseases, particularly gastrointestinal disorders and cancer, also contribute to the demand for advanced endoscopy devices in this region.

Asia Pacific: Fastest growing region with the highest market CAGR

The Asia-Pacific region is the fastest-growing market for robotic endoscopy devices, with high compound annual growth rates (CAGR) fueled by increased healthcare spending, expanding patient populations, and rising demand for minimally invasive procedures. Governments in countries like China, India, and Japan are investing heavily in healthcare infrastructure, enhancing access to advanced medical technologies. The launch of new products and strategic partnerships between global and local companies are further propelling market growth.

Country Insights

The global robotic endoscopy devices market is experiencing dynamic growth and diversification across the globe, with each region contributing uniquely to the advancement of this transformative field. As countries invest in research and product development, they shape the market landscape in distinctive ways.

This section analyses key developments, market leaders, and regulatory environments across various countries, illustrating how their unique contributions and strategies drive the evolution of robotic endoscopy devices and impact the future of healthcare.

Below are a few countries that illustrate the diverse contributions and advancements in the global market;

• U.S. - The U.S. is a dominant force in North America and globally for technological innovation in robotic endoscopy. It is home to major market players like Stryker Corporation, Olympus Corporation, and Johnson & Johnson, which drive advancements and set industry standards. The U.S.’s well-established R&D ecosystem, combined with strong investment in healthcare technology, supports its leadership in this market.
• Germany - As a leader in the medical device industry, Germany is instrumental in the development of advanced medical technologies, including robotic endoscopy. High healthcare expenditure and increasing adoption of robotic devices across hospitals highlight Germany's pivotal role and robust infrastructure in advancing robotic surgical technologies.
• Japan- Japan leads in robotic endoscopy innovation, primarily driven by its aging population and commitment to high healthcare standards. Companies like Olympus Corporation are at the forefront of technologies that enhance surgical precision. According to The Asahi Shimbun, Japan’s elderly population reached 36.25 million in 2023, underscoring the demand for advanced medical solutions in the country.
• UK - In the UK, the robotic endoscopy industry’s growth is driven by the National Health Service's efforts to modernize surgical practices. Despite regulatory challenges and budget constraints, there is a growing acceptance of robotic technologies among surgeons and patients. For instance, according to the Private Healthcare Information Network, there is a rise of 341% across the NHS and independent sector in robot-assisted surgeries.

• France- France benefits from the robust governmental support for healthcare innovation, coupled with growing innovation in the medical technology industry. This supportive environment promotes the integration of robotic endoscopy, thereby improving surgical results and patient care through the use of advanced technology.
• India - India is making notable advancements in its medical device industry, driven by greater access to healthcare and rising demand for surgical interventions. An expanding network of private hospitals is investing in robotic systems to meet the demand for sophisticated medical technology. Although India’s per capita healthcare spending was only $211, with $16 allocated to medical technology in 2023, increased healthcare expenditure is fostering industry growth.

• China - China’s rapid economic growth and substantial healthcare investments make it an attractive market for key players. The large patient base and frequent new product launches are boosting the market. For example, in November 2023, Olympus Corporation introduced its next-generation EVIS X1 endoscopy system in China, strengthening the country’s market presence in robotic endoscopy solutions.

Robotic Endoscopy Devices Market Segmentation Analysis

By Product

The therapeutic segment leads the global market in terms of revenue, driven by the increasing prevalence of gastrointestinal diseases. As these chronic conditions become more widespread, there is a growing demand for robotic endoscopes tailored for therapeutic applications.

• For example, the National Institutes of Health (NIH) reports that gastrointestinal complications are prevalent in India, with conditions like diarrhea, constipation, and irritable bowel syndrome affecting 4.7%, 11.7%, and 4.1% of the population, respectively.

By Applications

The laparoscopy segment dominates the global market due to its minimally invasive nature, offering benefits such as reduced recovery times and enhanced procedural precision. Rising numbers of laparoscopic surgeries, along with technological advancements and increased surgeon acceptance, further propel this segment's growth.

• For instance, approximately 15.2 million laparoscopic procedures were performed in 2023, reflecting the demand for minimally invasive solutions.

By End-User

The hospitals segment generates the highest revenue, largely due to the high volume of surgeries conducted in hospital settings. Hospitals continue to invest significantly in advanced technologies to enhance patient care, improve surgical outcomes, and stay competitive. Moreover, hospitals provide specialized surgical expertise and have access to a broad patient base, which supports the adoption of robotic systems.

Company Market Share

Key market players are developing and integrating new technologies into their products to improve diagnostic and surgical outcomes. These market key players are also expanding their market presence in developing countries. Moreover, players also focus on adopting key business strategies, such as strategic collaborations, acquisitions, innovative partnerships, product launches, and product approval.

Olympus Corporation: An emerging player in the global robotic endoscopy devices market

Olympus Corporation, a medical technology company, is gaining a strong foothold in the robotic endoscopy industry by developing advanced artificial intelligence-enabled devices. The company is also advancing promising disease areas for diagnosis, such as Crohn’s disease, Celiac disease, and colorectal cancer.

Recent developments by Olympus Corporation:

• In October 2023, Olympus Corporation launched its next-generation EVIS X1 endoscopy system, demonstrated on October 22-24, during the American College of Gastroenterology Meeting in Canada. Key features of these systems include Texture and Colour Enhancement Imaging technology, Red Dichromatic Imaging technology, and Narrow Band Imaging technology.

Recent Developments

• September 2024 - Hong Kong and Switzerland recently conducted a groundbreaking remote tele-endoscopy pilot, performing a biopsy on a porcine model across a 5,700-mile distance. This procedure used a magnetic endoscope and robotic platform, proving the feasibility of telesurgery over vast distances.
• January 2024 - EndoQuest Robotics, Inc., a medical device company, entered into a partnership with OmniVision, a leading global developer of semiconductor solutions. This partnership will integrate OMNIVISION's OCHFA CameraCubeChip into EndoQuest's Flexible Robotic System.

Analyst Opinion

As per our analysts, the global market is experiencing strong growth fueled by rapid technological advancements, a growing preference for minimally invasive surgeries, and the rising geriatric population. The market is highly dynamic, with significant expansion potential, especially in emerging regions where the medical device industry is rapidly developing.

Our analysts predict that ongoing research and development efforts, coupled with favorable regulatory frameworks, will continue to accelerate the growth of the robotic endoscopy market. With these factors in place, the industry is poised for substantial long-term growth and innovation.